Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13672217 | 0.88 | EPHX1 (0.46) | EPHX1TSHR | |
| SCHEMBL2831544 | 0.86 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL14653044 | 0.86 | EPHX1 (0.45) | EPHX1TSHRMEN1KMT2ATHRB | |
| SCHEMBL20005877 | 0.84 | EPHX1 (0.43) | EPHX1MEN1KMT2ATHRBHTT | |
| SCHEMBL2825441 | 0.84 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL2828604 | 0.84 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL2827671 | 0.84 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL2829720 | 0.84 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL8831115 | 0.82 | EPHX1 (0.42) | EPHX1TSHR | |
| SCHEMBL1978276 | 0.81 | EPHX1 (0.50) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842388-B2 | Functional polymers via surface modifying agents | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-11-30 | — | — | US | disclosed |
| US-7771793-B2 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-08-10 | — | — | US | disclosed |
| US-7659413-B2 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2010-02-09 | — | — | US | disclosed |
| EP-1713787-B1 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KK (JP) | 2009-12-30 | — | — | EP | disclosed |
| US-20070060760-A1 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1713787-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2006-10-25 | — | — | EP | disclosed |
| US-20060194065-A1 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2006-08-31 | — | — | US | disclosed |
| US-20060154083-A1 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2006-07-13 | — | — | US | disclosed |
| WO-2005075445-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060760-A1 | (Meth) acryloyl group-containing oxetane compound and production method thereof | OXGR1, ALKBH2, OXER1 | EPHX1 2348/4885TSHR 2809/4885MAPK1 1946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.